))
5 Common Clinical Trial Site Failures
Manage episode 457646172 series 3506216
Sisällön tarjoaa Darshan Kulkarni. Darshan Kulkarni tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Darshan discusses the five most common clinical trial site issues:
1. Failure to Follow Investigational Plan: Treating clinical trials like routine medical practice instead of strictly following the protocol can lead to serious issues.
2. Inadequate and Inaccurate Records: The FDA emphasizes that if it’s not documented, it didn’t happen. Inaccurate records can lead to compliance problems.
3. Inadequate Drug Accountability: Not knowing where your investigational product has gone is a major issue. The FDA expects thorough tracking and accountability.
4. Failure to Obtain and Document Subject Consent: Consent issues are a big problem, with 9% of clinical trial issues related to improper or insufficient documentation of consent.
5. Inadequate Subject Consent: Obtaining consent is critical, and inadequate consent is a common and problematic issue.
For help with clinical trial compliance, contact Darshan.
164 jaksoa
Jaa
